Clinical Trial Update: NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating near-infrared fluorescence imaging during neck dissection in head and neck cancer patients after intravenous indocyan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN